News
Folate Intake Linked to Reduced Cardiovascular Risk in Dysglycemia Patients
5 September 2025
Folate consumption from foods or supplements can lower cardiovascular risk in the general population. Recent research suggests that folate may be a modifiable factor in diabetes therapies.
Quatrefolic® is a natural solution that reduces cardiovascular risk and improves prediabetes health conditions and insulin resistance.
Numerous studies have demonstrated that folate consumption, whether from dietary sources or supplements, can effectively limit compromised cardiovascular health in the general population. This essential nutrient is crucial in regulating homocysteine levels, a known risk factor for various heart-related conditions.
In a groundbreaking study, researchers have uncovered the potential protective effects of folate consumption on mortality rates among individuals with dysglycemia, including prediabetes, diabetes, and insulin resistance.
The study, which analyzed data from the National Health and Nutrition Examination Survey (NHANES), revealed that higher daily folate intake was significantly and inversely associated with all-cause mortality, especially cardiovascular disease, in patients with dysglycemic conditions.
In addition, by incorporating folate-rich foods or supplements into their daily routines, individuals with prediabetes, diabetes, or insulin resistance may be able to improve their long-term health outcomes significantly.
These findings suggest that people with dysglycemia may benefit significantly from folate consumption, such as Quatrefolic®.
